P K Morrish

Summary

Affiliation: Cardiff University
Country: UK

Publications

  1. pmc Measuring the rate of progression and estimating the preclinical period of Parkinson's disease with [18F]dopa PET
    P K Morrish
    MRC Cyclotron Unit Hammersmith Hospital, London, UK
    J Neurol Neurosurg Psychiatry 64:314-9. 1998
  2. pmc Statistical parametric mapping with 18F-dopa PET shows bilaterally reduced striatal and nigral dopaminergic function in early Parkinson's disease
    K Ito
    MRC Cyclotron Unit, Hammersmith Hospital, London, UK
    J Neurol Neurosurg Psychiatry 66:754-8. 1999
  3. ncbi request reprint Frontal, midbrain and striatal dopaminergic function in early and advanced Parkinson's disease A 3D [(18)F]dopa-PET study
    J S Rakshi
    MRC Cyclotron Unit, Hammersmith Hospital, The Wellcome Department of Cognitive Neurology, Institute of Neurology, London, UK
    Brain 122:1637-50. 1999
  4. ncbi request reprint A comparison of the progression of early Parkinson's disease in patients started on ropinirole or L-dopa: an 18F-dopa PET study
    J S Rakshi
    MRC Clinical Sciences Centre Imperial College School of Medicine, Hammersmith Hospital, London, UK
    J Neural Transm 109:1433-43. 2002

Collaborators

Detail Information

Publications4

  1. pmc Measuring the rate of progression and estimating the preclinical period of Parkinson's disease with [18F]dopa PET
    P K Morrish
    MRC Cyclotron Unit Hammersmith Hospital, London, UK
    J Neurol Neurosurg Psychiatry 64:314-9. 1998
    ....
  2. pmc Statistical parametric mapping with 18F-dopa PET shows bilaterally reduced striatal and nigral dopaminergic function in early Parkinson's disease
    K Ito
    MRC Cyclotron Unit, Hammersmith Hospital, London, UK
    J Neurol Neurosurg Psychiatry 66:754-8. 1999
    ..To apply statistical parametric mapping to 18F-dopa PET data sets, to examine the regional distribution of changes in dopaminergic metabolism in early asymmetric Parkinson's disease...
  3. ncbi request reprint Frontal, midbrain and striatal dopaminergic function in early and advanced Parkinson's disease A 3D [(18)F]dopa-PET study
    J S Rakshi
    MRC Cyclotron Unit, Hammersmith Hospital, The Wellcome Department of Cognitive Neurology, Institute of Neurology, London, UK
    Brain 122:1637-50. 1999
    ..This suggests, therefore, that Parkinson's disease is a monoaminergic neurodegenerative disorder...
  4. ncbi request reprint A comparison of the progression of early Parkinson's disease in patients started on ropinirole or L-dopa: an 18F-dopa PET study
    J S Rakshi
    MRC Clinical Sciences Centre Imperial College School of Medicine, Hammersmith Hospital, London, UK
    J Neural Transm 109:1433-43. 2002
    ..To study the relative rates of progression of early Parkinson's disease (PD) in patients started on a dopamine agonist, ropinirole, or L-dopa...